| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 30.753 | 193.116 | 424.112 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 30.782 | 194.898 | 424.550 |
| Total Expenses - EUR | - | - | - | - | - | - | 499 | 230.191 | 376.016 | 581.321 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -499 | -199.409 | -181.118 | -156.770 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -499 | -200.208 | -181.118 | -156.770 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Zitamine Nutrition S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 13.939 | 32.229 |
| Current Assets | - | - | - | - | - | - | 102.013 | 97.870 | 216.084 | 104.078 |
| Inventories | - | - | - | - | - | - | 11.185 | 21.652 | 35.874 | 42.687 |
| Receivables | - | - | - | - | - | - | 0 | 11.672 | 23.310 | 22.407 |
| Cash | - | - | - | - | - | - | 90.828 | 64.547 | 156.900 | 38.985 |
| Shareholders Funds | - | - | - | - | - | - | -496 | -200.506 | -90.909 | -249.565 |
| Social Capital | - | - | - | - | - | - | 2 | 203 | 253 | 251 |
| Debts | - | - | - | - | - | - | 102.510 | 298.376 | 320.931 | 385.872 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Zitamine Nutrition S.r.l.